DIAGNOSTIC AND THERAPEUTIC METHODS FOR CORNEAL ECTASIA FOLLOWING REFRACTIVE SURGERY, KERATOCONUS OR PELLUCID DEGENERATION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130058954A1
SERIAL NO

13513800

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods of diagnosis and treatment of corneal ectasia following refractive surgery, keratoconus or pellucid marginal degeneration in a subject by determining or modulating the level of expression of molecules associated with the Wnt signalling pathway. Marker molecules of the present invention include SFRP1, PITX2, LEF1, WNT16 and WNT5A.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNIVERSITY OF SYDNEYSYDNEY NEW SOUTH WALES

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Madigan, Michele Hurlstone Park, AU 2 11
McAvoy, John Stanmore, AU 5 85
Sutton, Gerard Balmoral, AU 5 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation